PHARMADULE ACHIEVES ECOVADIS GOLD RATING!
We are thrilled to announce that Pharmadule Morimatsu AB has renewed its sustainability rating with EcoVadis! In January...
We are thrilled to announce that Pharmadule Morimatsu AB has renewed its sustainability rating with EcoVadis! In January...
We are excited to invite you to visit Pharmadule at booth #205 during the 2025 ISPE Facility of the Future Conference! Join...
Pharmadule Morimatsu has successfully completed all 250 modules for client's new ADC facility in Singapore!
Pharmadule is expanding its global footprint with a new sales office in France. This strategic move allows us to better serve...
Pharmadule Morimatsu is proud to announce the opening of our new sales office in Dublin, Ireland. By establishing an office...
Pharmadule Morimatsu will deliver a modular turn-key facility to Egyptian International Pharmaceutical Industries, EIPICO,...
Pharmadule Morimatsu has completed and shipped a turn-key modular vaccine facility to Morocco, Africa. The facility consists...
Pharmadule Morimatsu has successfully completed the first SARS CoV-2 mRNA vaccine production plant to Chinese vaccine manufacturer...
Pharmadule Morimatsu expands the operation by opening an office in Milan, Italy. The Italian office will serve as a hub for...
On the afternoon of 28 June 2021, Morimatsu International Holdings Ltd. (hereinafter as “Morimatsu International”) was officially...
On the December 12th 2019, with the last six modules being lift and placed within one day, 54 modules designed and fabricated...